GLOBAL HEALTH | GLOBAL PARTNERSHIPS | GLOBAL IMPACT

Research

Photo for PIAAF-Home (SCREEN-AF)

PIAAF-Home (SCREEN-AF)

Official Title

Program for Identification of “Actionable” Atrial Fibrillation (PIAAF): Home-Based Screening for Early Detection of Atrial Fibrillation in Primary Care Patients Aged 75 Years and Older: the SCREEN-AF Randomized Trial

Status

Ongoing

Overview

To offer patients new technologies to detect AF using a wearable ECG patch and a blood pressure machine that has the ability to detect AF. The aim is to establish a practical and cost-effective screening strategy that could be easily applied in primary care for early detection and treatment of AF. The SCREEN-AF trial is a Canadian multicenter study of atrial fibrillation (AF) screening being conducted in a home based setting.

Study Design

Cohort study

Primary Endpoint

The primary outcome will be the new diagnosis of ECG-confirmed atrial fibrillation or flutter within 6 months post randomization.

Number of Patients

822

Number of Sites

30

Number of Countries

1

Study Period

2015–2016

Principal Investigator

David Gladstone, Noah Ivers, F. Russell Quinn, Jeff Healey

Program Manager

Kimberly Begley

Research Coordinator

Alex Grinvalds